ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      -0.16%
      US Tech 100
      19,220.00
      -0.20%
      Dow Jones
      39,150.33
      0.04%
      Brent Oil
      84.39
      0.00%
      Bitcoin
      64,245.22
      0.25%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Exel Industries (EXE) Quote

      Exel Industries

      Exel Industries (EXE)

      Extendicare Inc
      50.00
      0.00
      (0.00%)
      Closed June 22 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      50.00
      Bid
      49.90
      Ask
      50.20
      Volume
      198
      49.90 Day's Range 50.00
      40.60 52 Week Range 60.00
      Market Cap
      339.122M
      Previous Close
      50.00
      Open
      50.00
      Last Trade
      20
      @
      50
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,620
      Shares Outstanding
      6,782,437
      Dividend Yield
      3.14%
      PE Ratio
      7.98
      Earnings Per Share (EPS)
      6.27
      Revenue
      1.11B
      Net Profit
      42.5M

      About Exel Industries

      Sector
      Farm & Garden Mach & Eq-whsl
      Industry
      Farm & Garden Mach & Eq-whsl
      Website
      www.exel-industries.com
      Headquarters
      Epernay, Marne, Fra
      Founded
      1970
      Exel Industries is listed in the Farm & Garden Mach & Eq-whsl sector of the Euronext with ticker EXE. The last closing price for Exel Industries was 50.00 €. Over the last year, Exel Industries shares have traded in a share price range of 40.60 € to 60.00 €.

      Exel Industries currently has 6,782,437 shares outstanding. The market capitalization of Exel Industries is 339.12 € million. Exel Industries has a price to earnings ratio (PE ratio) of 7.98.

      EXE Latest News

      More News

      EXEL Industries: Number of shares and voting rights as of 05.31.2024

      EXEL Industries: Number of shares and voting rights as of 05.31.2024 EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206...

      June 05 2024
      GlobeNewswire Inc.

      EXEL Industries : Nombre d'actions et de droits de vote au 31.05.2024

      EXEL Industries : Nombre d'actions et de droits de vote au 31.05.2024 EXEL IndustriesSociété Anonyme au capital de 16 969 750 €Siège social : 54, rue Marcel Paul 51206 Epernay CedexRCS...

      June 05 2024
      GlobeNewswire Inc.

      EXEL Industries : résultats semestriels 2023–2024

      EXEL Industries : résultats semestriels 2023–2024 Résultats semestriels 2023–2024 Progression de l’EBITDA malgré des ventes stables Au premier semestre 2023–2024, EXEL Industries réalise un...

      May 24 2024
      GlobeNewswire Inc.

      EXEL Industries: first half 2023–2024 results

      EXEL Industries: first half 2023–2024 results First half 2023‐2024 results EBITDA grew despite stable sales EXEL Industries posted revenue of €492.7 million for the first half of 2023-2024...

      May 24 2024
      GlobeNewswire Inc.

      EXEL Industries: Number of shares and voting rights as of 04.30.2024

      EXEL Industries: Number of shares and voting rights as of 04.30.2024 EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206...

      May 07 2024
      GlobeNewswire Inc.

      EXEL Industries : Nombre d'actions et de droits de vote au 31.03.2024

      EXEL Industries : Nombre d'actions et de droits de vote au 31.03.2024 EXEL IndustriesSociété Anonyme au capital de 16 969 750 €Siège social : 54, rue Marcel Paul 51206 Epernay CedexRCS...

      May 06 2024
      GlobeNewswire Inc.

      EXEL Industries : Chiffre d’affaires 1er trimestre 2023–2024 + 1,8 %

      EXEL Industries : Chiffre d’affaires 1er trimestre 2023–2024 + 1,8 % Chiffre d’affaires 2e trimestre 2023–2024 : - 1,8 % Des ventes contrastées selon les activités Chiffre d'affaires...

      April 24 2024
      GlobeNewswire Inc.

      EXEL Industries : Nombre d'actions et de droits de vote au 29.02.2024

      EXEL Industries : Nombre d'actions et de droits de vote au 29.02.2024 EXEL IndustriesSociété Anonyme au capital de 16 969 750 €Siège social : 54, rue Marcel Paul 51206 Epernay CedexRCS...

      March 07 2024
      GlobeNewswire Inc.

      EXEL Industries : Nombre d'actions et de droits de vote au 31.01.2024

      EXEL Industries : Nombre d'actions et de droits de vote au 31.01.2024 EXEL IndustriesSociété Anonyme au capital de 16 969 750 €Siège social : 54, rue Marcel Paul 51206 Epernay CedexRCS...

      February 28 2024
      GlobeNewswire Inc.

      EXEL Industries : Résultats du vote sur les projets de résolutions

      EXEL Industries : Résultats du vote sur les projets de résolutions Assemblée générale ordinaire du 6 février 2024 Toutes les résolutions adoptées Les 19 résolutions soumises au vote des...

      February 06 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-4.2-7.7490774907754.254.248.4505849.55943456DE
      4-2.6-4.9429657794752.658.848.4342853.1296498DE
      12-5.8-10.39426523355.858.848.4162053.7272229DE
      260.81.6260162601649.26048.4119454.54305231DE
      52-0.2-0.39840637450250.26040.687352.23432795DE
      156-40-44.44444444449092.433.899657.62309211DE
      260-4.2-7.7490774907754.292.431138747.62344808DE

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AREBAmerican Rebel Holdings Inc
      $ 0.76
      (152.49%)
      		371.46M
      SHCRSharecare Inc
      $ 1.365
      (76.27%)
      		56.33M
      NXLNexalin Technologies Inc
      $ 1.7499
      (59.08%)
      		57.58M
      FUFUBitFuFu Inc
      $ 6.1209
      (56.95%)
      		2.5M
      SPECSpectaire Holdings Inc
      $ 0.50
      (47.06%)
      		65.27M
      FLFVFeutune Light Acquisition Corporation
      $ 2.5502
      (-69.75%)
      		862.38k
      FLFVUFeutune Light Acquisition Corporation
      $ 2.75
      (-66.83%)
      		16.5k
      RWODRedwoods Acquisition Corporation
      $ 2.34
      (-60.34%)
      		155.96k
      KAVLKaival Brands Innovations Group Inc
      $ 1.23
      (-57.14%)
      		4.92M
      RWODURedwoods Acquisition Corporation
      $ 3.24
      (-56.28%)
      		1.47k
      NVDANVIDIA Corporation
      $ 126.57
      (-3.22%)
      		658.13M
      AREBAmerican Rebel Holdings Inc
      $ 0.76
      (152.49%)
      		371.46M
      SIRISirius XM Holdings Inc
      $ 2.94
      (1.38%)
      		330.66M
      AAPLApple Inc
      $ 207.49
      (-1.04%)
      		246.38M
      NKLANikola Corporation
      $ 0.3466
      (5.16%)
      		193.36M

      Discussion

      View Full Feed
      Green Leaf Smoker Green Leaf Smoker 4 minutes ago
      As much as Phil'lippers want to cover their eyes & ears on this assessment they know what we we all know that your spot on w/ your assessment.
      PHIL
      janice shell janice shell 5 minutes ago
      Junk stocks every one...
      GME
      Nemesis18 Nemesis18 5 minutes ago
      Unfortunately, it is those very emotions surrounding a diagnosis of cancer, that is used by some to attempt to sell a product, whose efficacy doesn't quite match the price point.

      Sure there are stepping stones in the development of new treatments, but do not get there by massively ove
      NWBO
      meirluc meirluc 5 minutes ago
      If it were true that it will take one more year for the MHRA to validate
      the utilization of the Flaskworks, it will also take the same amount of
      time before NWBO can submit a BLA to the FDA because IMHO
      the validation of the Flaskworks is a prerequisite for the BLA.
      NWBO
      janice shell janice shell 6 minutes ago
      Nah. I really don't think anyone's sweating about GME.
      GME
      Bubae Bubae 6 minutes ago
      The only place that you will find a bed count in a filing for this treatment center is in the regulation "A" offering prospectus last amended October 2023. Up to a potential of 52 beds is all that we know for certain. Initially in the FAQ page for July 2021 they claimed that they would have 54 beds
      GRST
      Milan3902 Milan3902 6 minutes ago
      Let’s face facts if we still hold we will lose more money make your decision.
      FFIE
      Jimmy Joe Jimmy Joe 7 minutes ago
      Explain why it is not sustainable.

      Well yeah it did pop to 4.76 but that's not sustainable.

      Give details please.

      TIA.

      $AMC baby~!
      AMC
      xoom xoom 7 minutes ago
      16:00:01 Is a buy
      COOP
      Whalatane Whalatane 9 minutes ago
      By the way. Cash Position: As of March 31, 2024, cash and cash equivalents totaled $48.9 million.
      Co is losing about $20m a Qt running this trial ....so expect an immediate cash raise ...or warrant holders exercising some of their warrants if stock really pops on results .
      Either way
      UNCY
      DesertDrifter DesertDrifter 9 minutes ago
      https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/448984954_10226340862447735_4966858942583752611_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=5f2048&_nc_ohc=blW7IUrx7h0Q7kNvgGWL_wg&_nc_ht=scontent-lax3-2.xx&oh=00_AYD8iZw8M-iQRWazAAkD5bjYdv2RQazvezy4wrkFfw67DQ&oe=667CD50A

      https://scontent-lax3-
      Penny2Dime Penny2Dime 9 minutes ago
      OS is locked?!
      ATIG
      tjvs tjvs 9 minutes ago
      BBW sends me private nasty messages I guess he can't make it public lol
      TSOI
      drugrunner drugrunner 9 minutes ago
      You call yourself a skeptic. We all know that’s garbage. You are a paid basher.
      NWBO
      misterfishman misterfishman 9 minutes ago
      You here to start trouble Marcus.
      IGPK
      drugrunner drugrunner 9 minutes ago
      It’s amazing how you can find 1 million red flags about this company but not one good reason for them to be in existence. Even though they’ve had a successful phase 3 trial in are about to have their Drug approved. All you see is gloom and. Doom
      NWBO
      Boiler_Master Boiler_Master 11 minutes ago
      The fud basher video the CEO has been referring to is reposted on YouTube, after removing any copyright concerns (showing their website). It's titled "AITX Called This Bashing & Fud, You Decide"
      AITX
      jhdf51 jhdf51 11 minutes ago
      says sell?

      JHD
      COOP
      Kap10jak Kap10jak 11 minutes ago
      You also need to be a share holder.
      NWBO
      crescentmotor crescentmotor 11 minutes ago
      I think tens of billions of dollars is the right range for blarcamesine.

      The article assigned a Aducanumab value to Biogen (53.2% profit split) of $10.6 billion as a Phase III drug prior to approval. AVXL's market cap is $0.345 billion. It's hard to believe the market's valuation di
      AVXL
      Moonboy1 Moonboy1 12 minutes ago
      Like I always say and said it the other day. Up 5% take profit. What just happened? It was up 5% for about what 5 minutes haha. By the time I get alerts that tell me it's up 5% it's already usually sold off. Drive be from my house to the gym and all profit gone already
      SHIBUSD
      BDEZ BDEZ 14 minutes ago
      Good, one reason we purchased 4 in the last 15 plus years...

      Your Recent History

      EU
      EXE
      Exel Industries
      Delayed Upgrade Clock